Agilent Q4 Revenues Climb 35 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today reported revenues for its fiscal 2010 fourth quarter of $1.58 billion, up 35 percent from a year ago and surpassing analyst estimates of $1.52 billion.

A year ago, the company posted revenues $1.17 billion. Excluding the effects of the Varian acquisition and recent divestitures, revenues for the three months ended Oct. 31 were up 26 percent, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.